Broncus Medical-B (02216): Termination of Further Acquisition of Valgen Holding Corporation Equity

Zhito Finance APP News: Broncus Medical-B (02216) announced that regarding the further acquisition of 3.85% equity interest in Valgen Holding Corporation, after further discussions between Broncus China Holding Corporation (the buyer), a wholly-owned subsidiary of the company, and Max Grand Limited (the seller), the buyer and the seller entered into a termination agreement on September 20, 2026 to terminate the share transfer agreement, effective from the date of signing of the termination agreement.